Joined Today: 3

PCYC Pharmacyclics, Stock Message Board

All Messages

PCYC Message Board Home | Join The PCYC Group |

#5: PCYC Stock: Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
Financial Crisis	December 22, 2008 12:09:06 PM
- Trial Completed Ahead of Schedule; Drug Appears Very Well Tolerated with Precise Pharmacologic Effect - SUNNYVALE, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. ... view message ignore post recommend post

#4: Pharmacyclics, Inc. Announces Board and Management Transitions
TheMachine	September 20, 2008 12:22:15 PM
SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (the 'Company' or 'Pharmacyclics') announced today that Christine A. White, M.D.,... view message ignore post recommend post

#3: Pharmacyclics Reports Third Quarter 2008 Financial Results
Stock News Bot	April 27, 2008 02:08:42 PM
- Company to Host Conference Call at 4:30 p.m. EDT Today - SUNNYVALE, Calif., April 24 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today reported financial results... view message ignore post recommend post

#2: Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
Stock News Bot	December 22, 2007 04:58:50 AM
Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that it has received a non-approvable letter from the U.S. Food and Drug Administration (FDA) for the company's new drug application (NDA) for... view message ignore post recommend post

#1: PCYC News Rodman & Renshaw, LLC Announces Investment Opinion on Pharmacyclics
Stock News Bot	November 8, 2005 09:05:00 AM
NEW YORK--(BUSINESS WIRE)--Nov. 8, 2005--Rodman & Renshaw, LLC -- Rodman & Renshaw, LLC Initiates Coverage of Pharmacyclics With A Market Outperform Rating -- Analyst Sets 12 Month Target Price... view message ignore post recommend post

Group Home | Login if you want to post a message